Hematology
3 drugs are in development for Paroxysmal Nocturnal Hemoglobinuria.
- Companies
- 2
- Clinical trials
- 18
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Paroxysmal Nocturnal Hemoglobinuria pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Approved(2)
Phase 1(1)
| Drug | Company |
|---|---|
| oms906 | OMEROS CORP (OMER) |
About this indication
Paroxysmal Nocturnal Hemoglobinuria context
Hematology·MeSH: Hemoglobinuria, Paroxysmal (D006457)
Frequently asked questions
How many drugs are in development for Paroxysmal Nocturnal Hemoglobinuria?
BioSniper tracks 3 drugs in development for Paroxysmal Nocturnal Hemoglobinuria across 2 companies.
How many clinical trials target Paroxysmal Nocturnal Hemoglobinuria?
There are 18 clinical trials targeting Paroxysmal Nocturnal Hemoglobinuria tracked by BioSniper.